First Time Loading...

Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 67.01 USD -0.95% Market Closed
Updated: May 16, 2024

Gilead Sciences Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gilead Sciences Inc
Selling, General & Administrative Peer Comparison

Comparables:
ABBV
AMGN
MRNA
VRTX
REGN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Gilead Sciences Inc
NASDAQ:GILD
Selling, General & Administrative
-$6.1B
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
Abbvie Inc
NYSE:ABBV
Selling, General & Administrative
-$12.7B
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Amgen Inc
NASDAQ:AMGN
Selling, General & Administrative
-$6.7B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Moderna Inc
NASDAQ:MRNA
Selling, General & Administrative
-$1.5B
CAGR 3-Years
-85%
CAGR 5-Years
-71%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Selling, General & Administrative
-$1.1B
CAGR 3-Years
-14%
CAGR 5-Years
-15%
CAGR 10-Years
-12%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Selling, General & Administrative
-$2.7B
CAGR 3-Years
-25%
CAGR 5-Years
-12%
CAGR 10-Years
-23%

See Also

What is Gilead Sciences Inc's Selling, General & Administrative?
Selling, General & Administrative
-6.1B USD

Based on the financial report for Mar 31, 2024, Gilead Sciences Inc's Selling, General & Administrative amounts to -6.1B USD.

What is Gilead Sciences Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-13%

Over the last year, the Selling, General & Administrative growth was -3%. The average annual Selling, General & Administrative growth rates for Gilead Sciences Inc have been -6% over the past three years , -8% over the past five years , and -13% over the past ten years .